RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
42 hedge funds and large institutions have $106M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2016 Q2 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$66.5M | |
2 | +$10.9M | |
3 | +$4.8M | |
4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$3.6M |
5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3.31M |
Top Sellers
No sellers this quarter